Announcements

Mineralys Therapeutics, Inc. filed a Form 8-K on August 11, 2026, disclosing the appointment of a new Chief Medical Officer effective August 10, 2026, and announcing financial results for the quarter ended June 30, 2026.

Griffon Corporation filed a Form 8-K with the SEC on August 11, 2026, disclosing that on August 10, 2026, the company entered into a Purchase Agreement to issue and sell $800 million aggregate principal amount of 6.25% senior notes due 2034.

A Form 4 filed with the SEC on August 11, 2026, discloses changes in beneficial ownership of DoorDash, Inc. (NASDAQ:DASH) Class A Common Stock by Chief Executive Officer and Director Tony Xu, reflecting transactions dated August 7, 2026.

DoorDash, Inc. filed a Form 8-K on August 11, 2026, disclosing that certain stockholders holding a majority of voting power approved the company's reincorporation from Delaware to Nevada by written consent on August 6, 2026.

Factorial Energy Inc. filed a current report on August 11, 2026, disclosing its financial results for the quarter ended June 30, 2026, along with an updated investor presentation released under Regulation FD.

Vor Biopharma Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, disclosing financial statements and operational information for the three and six months ended June 30, 2026.

SELLAS Life Sciences Group, Inc. filed its Form 10-Q with the SEC on August 11, 2026, covering the quarterly period ended June 30, 2026, disclosing balance sheet figures and share count changes for the first half of the fiscal year.